Price chart
Loading 1Y daily…
Financial overlay · last 12 quarters
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5.2B | $1.3B | $1.1B | $0.2B | 25.8% | 20.6% |
| 2025-12-31 | $5.3B | $0.7B | $1.0B | $0.9B | 12.7% | 19.7% |
| 2025-09-30 | $5.1B | $0.8B | $1.1B | $1.1B | 14.9% | 20.7% |
| 2025-06-30 | $5.1B | $0.8B | $0.9B | $1.1B | 15.7% | 18.6% |
| 2025-03-31 | $4.7B | $0.7B | $0.9B | $0.3B | 14.5% | 20.1% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
| 2024-09-30 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Earnings replay · last 20 reports
| Date | EPS actual | EPS est | Surprise |
|---|---|---|---|
| 2026-04-22 | 0.80 | 0.79 | +1.6% |
| 2026-02-04 | 0.80 | 0.78 | +2.4% |
| 2025-10-22 | 0.75 | 0.71 | +5.1% |
| 2025-07-23 | 0.53 | 0.48 | +9.7% |
| 2025-04-23 | 0.75 | 0.67 | +11.5% |
| 2025-02-05 | 0.70 | 0.66 | +6.6% |
| 2024-10-23 | 0.63 | 0.59 | +7.0% |
| 2024-07-24 | 0.62 | 0.58 | +6.5% |
| 2024-04-24 | 0.56 | 0.51 | +9.1% |
| 2024-01-31 | 0.55 | 0.51 | +7.3% |
| 2023-10-26 | 0.50 | 0.48 | +4.7% |
| 2023-07-27 | 0.53 | 0.49 | +8.2% |
| 2023-04-26 | 0.47 | 0.43 | +8.6% |
| 2023-02-01 | 0.45 | 0.47 | -4.6% |
| 2022-10-26 | 0.43 | 0.44 | -2.6% |
| 2022-07-27 | 0.44 | 0.42 | +4.0% |
| 2022-04-27 | 0.39 | 0.39 | +1.2% |
| 2022-02-02 | 0.45 | 0.44 | +2.5% |
| 2021-10-27 | 0.41 | 0.40 | +3.7% |
| 2021-07-27 | 0.40 | 0.37 | +7.3% |
Earnings markers are overlaid on the price chart above. Transcript summaries require PERPLEXITY_API_KEY (deferred to a follow-up).
Peer comparison · Healthcare
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| BSX ★ | $71B | 19.9 | 12.8 | 3.4 | 14.7 | 2.7 | 68.9% | 11.6% | 100.0% | 3.96% |
| LLY | $949B | 37.7 | 23.9 | 13.1 | 27.3 | 30.5 | 82.8% | 55.5% | 169.9% | 0.96% |
| UNH | $343B | 28.5 | 18.1 | 0.8 | 18.5 | 3.5 | 18.8% | 2.0% | 0.7% | 5.15% |
| JNJ | $537B | 25.8 | 17.5 | 5.6 | 16.6 | 6.6 | 68.0% | 9.9% | -52.9% | 2.33% |
| MRK | $286B | 32.6 | 12.1 | 4.3 | 11.2 | 6.2 | 76.7% | 4.9% | — | 4.92% |
| ABBV | $381B | 105.6 | 13.3 | 6.1 | 14.8 | -57.2 | 72.0% | 12.4% | -46.2% | 5.47% |
| PFE | $146B | 19.5 | 9.0 | 2.3 | 7.8 | 1.6 | 74.8% | 5.4% | -10.1% | 8.50% |
| TMO | $179B | 26.5 | 17.7 | 4.0 | 19.4 | 3.4 | 40.9% | 6.2% | 11.3% | 3.08% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Top institutional holders
Top-10 concentration: 36.76%
| Holder | Shares | % out |
|---|---|---|
| Blackrock Inc. | 131,822,037 | 8.87% |
| Vanguard Capital Management LLC | 96,411,568 | 6.49% |
| FMR, LLC | 74,226,395 | 4.99% |
| State Street Corporation | 67,986,847 | 4.57% |
| JPMORGAN CHASE & CO | 33,350,157 | 2.24% |
| Geode Capital Management, LLC | 33,285,757 | 2.24% |
| Primecap Management Company | 32,529,774 | 2.19% |
| Vanguard Portfolio Management LLC | 29,796,211 | 2.00% |
| Shaw D.E. & Co., Inc. | 24,312,352 | 1.64% |
| Bank of America Corporation | 22,756,646 | 1.53% |
Insider activity · 90d
No insider trades for BSX in last 90d.
Analyst estimates
yfinanceConsensus: strong_buy (mean 1.48387). Distribution requires FINNHUB_API_KEY.
SEC filings
| Form | Filed | Description | Action |
|---|---|---|---|
| 4 | 2026-06-01 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-21 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-21 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-21 | Insider transaction (Form 4) | view · |
| 8-K | 2026-05-18 | 8-K | view · |
| 8-K | 2026-05-18 | 8-K | view · |
| 4 | 2026-05-11 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-11 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-11 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-11 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-11 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-11 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-11 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-11 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-11 | Insider transaction (Form 4) | view · |
| 8-K | 2026-05-05 | 8-K | view · |
| 4 | 2026-05-04 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-04 | Insider transaction (Form 4) | view · |
| 10-Q | 2026-05-01 | 10-Q | view · |
| 8-K | 2026-04-22 | 8-K | view · |
| 8-K | 2026-03-30 | 8-K | view · |
| DEF 14A | 2026-03-18 | DEF 14A | view · |
| 4 | 2026-03-04 | Insider transaction (Form 4) | view · |
| 4 | 2026-03-04 | Insider transaction (Form 4) | view · |
| 4 | 2026-03-04 | Insider transaction (Form 4) | view · |
| 4 | 2026-03-04 | Insider transaction (Form 4) | view · |
| 4 | 2026-03-03 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-27 | Insider transaction (Form 4) | view · |
| 8-K | 2026-02-26 | 8-K | view · |
| 8-K | 2026-02-23 | 8-K | view · |
| 4 | 2026-02-18 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-18 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-18 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-18 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-18 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-18 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-18 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-18 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-17 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-17 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-17 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-17 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-17 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-17 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-17 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-17 | Insider transaction (Form 4) | view · |
| 10-K | 2026-02-17 | 10-K | view · |
| 8-K | 2026-02-05 | 8-K | view · |
| 8-K | 2026-02-04 | 8-K | view · |
| 4 | 2026-02-03 | Insider transaction (Form 4) | view · |
| 8-K | 2026-01-15 | CURRENT REPORT | view · |
| 8-K | 2026-01-15 | CURRENT REPORT | view · |
| 4 | 2025-12-02 | Insider transaction (Form 4) | view · |
| 4 | 2025-12-01 | Insider transaction (Form 4) | view · |
| 8-K | 2025-11-19 | 8-K | view · |
| 4 | 2025-11-14 | Insider transaction (Form 4) | view · |
| 4 | 2025-11-06 | Insider transaction (Form 4) | view · |
| 4 | 2025-11-04 | Insider transaction (Form 4) | view · |
| 10-Q | 2025-11-03 | 10-Q | view · |
| 4 | 2025-10-31 | Insider transaction (Form 4) | view · |
About
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides tec…